Randomized Placebo-Controlled Trial of Long-Term Treatment with Sibutramine in Mild to Moderate Obesity

Journal of Family Practice, June, 2001 by Ian G. Smith, Michael A. Goulder

[33.] Guy W. CGI global impression ECDEU assessment manual for psychopharmacology. Washington, DC: Department of Health, Education, and Welfare; 1976.

[34.] Winer BJ. In: Winer BJ, ed. Statistical principles in experimental design. 2nd ed. New York, NY: McGraw-Hill; 1971:261-308.

[35.] Hollander M, Wolfe DA. The two-sample location problem. In: Hollander M, Wolfe DA, eds. Nonparametric statistical methods. New York, NY: John Wiley & Sons; 1973:67-82.

[36.] Hollander M, Wolfe DA. The one-way layout. In: Hollander M, Wolfe DA, eds. Nonparametric statistical methods. New York, NY: John Wiley & Sons; 1973:114-20.

[37.] National Task Force on the Prevention and Treatment of Obesity. Long-term pharmacotherapy in the management of obesity. JAMA 1996; 276:1907-15.

[38.] Noel M, Hickner J, Ettenhofer T, Gauthier B. The high prevalence of obesity in Michigan primary care practices: an UPRNet study. J Fam Pract 1998; 47:39-43.

[39.] Guidelines Subcommittee of the World Health Organization-International Society of Hypertension Mild Hypertension Liaison Committee. 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension. J Hypertens 1999; 17:151-83.

[40.] Assmann G, Carmena R, Cullen P, et al. Coronary heart disease: reducing the risk. A worldwide view. Circulation 1999; 100:1930-38.

[41.] Hansson L. The Hypertension Optimal Treatment Study and the importance of lowering blood pressure. J Hypertens 1999; 17(suppl 1):S9-13.

[42.] Lapidus L, Bengtsson C, Larsson B, Pennert K, Rybo E, Sjostrom L. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. BMJ 1984; 289:1257-61.

[43.] Larsson B, Svardsudd K, Welin L, Wilhelmsen L, Bjorntorp P, Tibblin G. Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13-year follow-up of participants in the study of men born in 1913. BMJ 1984; 288:1401-04.

[44.] James WPT, Astrup A, Finer N, et al. Effect of sibutramine on weight maintenance after weight loss: a randomized trial. Lancet 2000; 356:2119-25.

IAN G. SMITH, MB, CHB, ON BEHALF OF THE MEMBERS OF THE SIBUTRAMINE CLINICAL STUDY 1047 TEAM; AND MICHAEL A. GOULDER, BSC Chorley and Nottingham, England

* Submitted, revised, February 25, 2001.

From Synexus LTD, Chorley (I.G.S.) and Biostatistics and Data Management, Knoll Limited, Nottingham (M.A.G.). Reprint requests should be addressed to Ian G. Smith, MB, ChB, Synexus LTD, Sandringham House, Ackhurst Park, Chorley PR7 1NY United Kingdom. E-mail: ian.smith@synexus.co.uk